SEC Delays Altcoin Rally with ETF Approval in Limbo
ByAinvest
Tuesday, Aug 26, 2025 7:35 am ET1min read
DOGE--
Currently, dozens of altcoin ETF proposals, including those tracking Solana (SOL), XRP (XRP), Hedera (HBAR), and Litecoin (LTC), are under review by the U.S. Securities and Exchange Commission (SEC). Industry optimism for approval remains high, with some ETFs having approval odds of up to 95% [1]. However, recent delays in the regulatory process have created uncertainty around the potential launch timeline.
The SEC has cited the need for additional review and has set October as the deadline for decisions on most proposals. This delay has pushed back the potential start of an altcoin season, which could have been fueled by the launch of these ETFs. The long-awaited rally may take more time to materialize as a result [1].
The regulatory review process for these ETFs is complex and involves multiple steps. The SEC has opened a 21-day public comment period on Canary’s proposed staked Injective ETF, which would track Injective’s native token (INJ) and list on the Cboe BZX Exchange [2]. The SEC’s review of this proposal and others like it is crucial for determining the future of altcoin ETFs and, consequently, the crypto market.
Analysts have noted that the approval of these ETFs could significantly impact the crypto market by attracting institutional capital and generating fresh demand. However, the ultimate verdict on these proposals rests with the regulatory watchdog, and it remains to be seen whether these funds will receive the greenlight needed to usher in the next altcoin season [1].
Investors and financial professionals should closely monitor the regulatory process and the market's reaction to any decisions made by the SEC. The approval of altcoin ETFs could transform the market dynamics of various cryptocurrencies, including Dogecoin (DOGE), which has a 60-70% chance of ETF approval within the next 12-18 months [3].
References:
[1] https://crypto.news/is-the-sec-delaying-altcoin-season-analysts-say-no-rally-until-etfs-launch/
[2] https://en.coinotag.com/sec-begins-review-of-canarys-staked-injective-etf-proposal-injective-inj-may-face-technical-pressure/
[3] https://coinpaper.com/10709/dogecoin-etf-approval-70-likely-prepare-for-massive-5-x-price-surge
HBAR--
LTC--
SOL--
XRP--
The crypto industry is awaiting an altcoin season, but analysts say it won't materialize until new exchange-traded funds (ETFs) launch. Dozens of altcoin ETF proposals are under SEC review, with some having approval odds of up to 95%. Industry optimism for approval remains high despite recent delays.
The crypto industry has been eagerly awaiting an altcoin season, but the anticipated rally has yet to materialize. Analysts attribute this delay to the regulatory review process of new exchange-traded funds (ETFs), specifically those focused on altcoins. According to a recent Bitfinex report, a sustained altcoin rally depends on the launch of these new ETFs [1].Currently, dozens of altcoin ETF proposals, including those tracking Solana (SOL), XRP (XRP), Hedera (HBAR), and Litecoin (LTC), are under review by the U.S. Securities and Exchange Commission (SEC). Industry optimism for approval remains high, with some ETFs having approval odds of up to 95% [1]. However, recent delays in the regulatory process have created uncertainty around the potential launch timeline.
The SEC has cited the need for additional review and has set October as the deadline for decisions on most proposals. This delay has pushed back the potential start of an altcoin season, which could have been fueled by the launch of these ETFs. The long-awaited rally may take more time to materialize as a result [1].
The regulatory review process for these ETFs is complex and involves multiple steps. The SEC has opened a 21-day public comment period on Canary’s proposed staked Injective ETF, which would track Injective’s native token (INJ) and list on the Cboe BZX Exchange [2]. The SEC’s review of this proposal and others like it is crucial for determining the future of altcoin ETFs and, consequently, the crypto market.
Analysts have noted that the approval of these ETFs could significantly impact the crypto market by attracting institutional capital and generating fresh demand. However, the ultimate verdict on these proposals rests with the regulatory watchdog, and it remains to be seen whether these funds will receive the greenlight needed to usher in the next altcoin season [1].
Investors and financial professionals should closely monitor the regulatory process and the market's reaction to any decisions made by the SEC. The approval of altcoin ETFs could transform the market dynamics of various cryptocurrencies, including Dogecoin (DOGE), which has a 60-70% chance of ETF approval within the next 12-18 months [3].
References:
[1] https://crypto.news/is-the-sec-delaying-altcoin-season-analysts-say-no-rally-until-etfs-launch/
[2] https://en.coinotag.com/sec-begins-review-of-canarys-staked-injective-etf-proposal-injective-inj-may-face-technical-pressure/
[3] https://coinpaper.com/10709/dogecoin-etf-approval-70-likely-prepare-for-massive-5-x-price-surge

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet